1. Hepatitis C in the HIV-infected patient
Mark S Sulkowski, MD, David L Thomas, MD 
Clinics in Liver Disease 
Volume 7, Issue 1, Pages (February 2003)
DOI: /S (02)

2. Fig. 1
Prevalence of anti-HCV in patients with HIV infection receiving medical care in the Johns Hopkins HIV Clinic (n = 1742) according to reported risk factor for HIV. (From: Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Annals Internal Medicine, in press; with permission.)
Abbreviations: IDU, injection drug use; MSM, men who have sex with men.
Clinics in Liver Disease 2003 7, DOI: ( /S (02) )

3. Fig. 2
Mortality among people with HIV in the United States and proportion related to liver disease. Data derived from death certificate reviews conducted by the Centers for Disease Control and Prevention. All deaths among people with HIV are included and shown declining in association with HAART. Liver disease is considered at the time hepatitis (ICD-9 = 070) or cirrhosis (ICD-9 = 570–573) is mentioned on the death certificate. (Data from Selik RM, Byers RH, Dworkin MS. Trends in diseases reported on U.S. Death Certificates thay mentioned HIV infection, 1987–1999. J AIDS 2002;29:378–87; with permission.)
Clinics in Liver Disease 2003 7, DOI: ( /S (02) )

4. Fig. 3
The incidence of various grades of hepatotoxicity in the Johns Hopkins HIV Clinic according to HCV status, as reported by Sulkowski et al in [46]
Clinics in Liver Disease 2003 7, DOI: ( /S (02) )